Search Results - "Oruc, Z."

The prognostic ad predictive value of primary tumor sidedness in the mCRC pts by Sezer, E., Eser, K., Onder, A., Ozturk, B., Ercolak, V., Oruc, Z.

Get full text

P-251The prognostic ad predictive value of primary tumor sidedness in the mCRC pts by Sezer, E, Eser, K, Onder, A, Ozturk, B, Ercolak, V, Oruc, Z

Get full text

Central nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncology by Seber, S, Turkmen, E, Harputoğlu, H, Yeşil, H, Arpacι, E, Menekşe, S, Pilancι, K, Oruç, Z, Taskoylu, B Y, Gumusay, O, Aksoy, A, Karaagac, M, Ozarslan, E, Yetisyigit, T

“…Central nervous system (CNS) metastasis is a rare event in the course of late stage epithelial ovarian cancer (EOC); however its incidence is increasing in…”
Get more information

An update on the currently available and future chemotherapy for treating bone metastases in breast cancer patients by Oruç, Zeynep, Kaplan, Muhammet Ali, Arslan, Çağatay

“…Bone metastases in breast cancer patients are a common clinical problem. Many factors influence the treatment decision, including tumor characteristics,…”
Get more information

Immunoglobulin class-switch recombination in mice devoid of any Sμ tandem repeat by Khamlichi, Ahmed Amine, Glaudet, Florence, Oruc, Zeliha, Denis, Vincent, Le Bert, Marc, Cogné, Michel

“…Immunoglobulin heavy-chain class-switch recombination (CSR) occurs between highly repetitive switch sequences located upstream of the constant region genes…”
Get full text

Abstract P6-14-04: Is fat mass more effective than body mass index (BMI) to predict toxicity in early breast cancer patients treated with doxorubicin and cyclophosphamide? by Kaplan, MA, Kavak, H, Urakci, Z, Nas, N, Oruç, Z, Yerlikaya, H, Akdeniz, N, Isikdogan, A

“…Abstract Patients and Methods:We performed a retrospective cohort study of 207 operated breast cancer women treated with doxorubicin (60 mg/m2) and…”
Get full text

Etude de l’effet néphrotoxique des complexes IgA–IgG dans un modèle murin de maladie de Berger by Druilhe, A., Oruc, Z., Archelus, A., Oblet, C., Thomas, M., Duchez, S., Aldigier, J.C., Cogné, M.

“…L’hématurie et la protéinurie caractéristiques de la maladie de Berger sont dues à un dysfonctionnement glomérulaire consécutif au dépôt mésangial…”
Get full text

Influence de l’environnement et caractéristiques des IgA au cours de la néphropathie à dépôts mésangiaux d’IgA by Aldigier, J.C., Oruc, Z., Oblet, C., Boumediene, A., Pascal, V., El Hamel, C., Lecardeur, S., Morelle, W., Demengeot, J., Cogné, M.

“…Le dépôt mésangial d’immunoglobuline (Ig) A1 est l’élément caractéristique de la néphropathie à dépôts d’IgA (IgAN) et du purpura rhumatoïde. Plusieurs…”
Get full text

Caractéristiques des IgA promptes à se déposer dans le mésangium by Aldigier, J.C., Oruc, Z., Oblet, C., Boumediene, A., Cuvillier, A., Le Rumeur, E., Pascal, V., Druilhe, A., Cogné, M.

“…Le dépôt mésangial d’immunoglobuline (Ig) A est l’élément caractéristique de la néphropathie à dépôts d’IgA et du purpura rhumatoïde. Plusieurs anomalies des…”
Get full text